High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo

A retrospective chart review of 4,925 human African trypanosomiasis patients treated with melarsoprol in 2001–2003 in Equateur Nord Province of the Democratic Republic of Congo showed a treatment failure rate of 19.5%. This rate increased over the 3 years. Relapse rates were highest in the central p...

Descripción completa

Detalles Bibliográficos
Autores principales: Robays, Jo, Nyamowala, Gaspard, Sese, Claude, Kande, Victor Betu Ku Mesu, Lutumba, Pascal, Van der Veken, Wim, Boelaert, Marleen
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2008
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600279/
https://www.ncbi.nlm.nih.gov/pubmed/18507916
http://dx.doi.org/10.3201/eid1406.71266
Descripción
Sumario:A retrospective chart review of 4,925 human African trypanosomiasis patients treated with melarsoprol in 2001–2003 in Equateur Nord Province of the Democratic Republic of Congo showed a treatment failure rate of 19.5%. This rate increased over the 3 years. Relapse rates were highest in the central part of the province.

Ejemplares similares